References
- Mégarbane B, Delahaye A, Goldgran-Tolédano D, Baud FJ. Antidotal treatment of cyanide poisoning. J Chin Med Assoc 2003; 66: 193–203
- Baud FJ. Cyanide: critical issues in diagnosis and treatment. Hum Exp Toxicol 2007; 26: 191–201
- Holland MA, Kozlowski LM. Clinical features and management of cyanide poisoning. Clin Pharm 1986; 5: 737–741
- Peddy SB, Rigby MR, Shaffner DH. Acute cyanide poisoning. Pediatr Crit Care Med 2006; 7: 79–82
- Centers for Disease Control and Prevention (CDC). Update: hydrogen cyanamide-related illnesses—Italy, 2002–2004. MMWR Morb Mortal Wkly Rep 2005; 54: 405–408
- Mégarbane B, Delahaye A, Goldgran-Tolédano D, Baud FJ. Antidotal treatment of cyanide poisoning. J Chin Med Assoc 2003; 66: 193–203
- Renard C, Borron SW, Renaudeau C, Baud FJ. Sodium thiosulfate for acute cyanide poisoning: study in a rat model. Ann Pharm Fr 2005; 63: 154–161
- Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol 2007; 25: 26–32
- Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006; 18: 396–402